15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Inogen Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $12.00 to $12.00, so the covering firms are broadly aligned. The average target of $12.00 sits 87% above the current $6.43. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.00 next quarter toward $-0.26 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Inogen Inc.
As of Jul, 1 of 1 firms rate INGN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
INGN EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 1 analysts · -100% YoY
Next period, 1 analysts expect Inogen Inc to earn $0.00 a share (range $0.00 – $0.00), versus $-0.02 a year earlier. Full-year consensus is $-0.37, growing to $-0.26 the year after.
REVENUE · NEXT QUARTER
$98.7M
Range $98.2M – $99.2M · 1 analysts · +7% YoY
Revenue is expected to reach $98.7M (range $98.2M – $99.2M), +6.8% year-over-year. Full-year consensus is $369.3M, rising to $396.8M next year.
Top analysts covering Inogen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INGN.
#1
Mike Matson
Needham · Rank #204
Buy
$12.00+86.6% to target
Overall win rate
31%
+ Follow
#2
AS
Anderson Schock
B. Riley Securities
Buy
$14.00+117.7% to target
Coverage
—
+ Follow
#3
Robbie Marcus
JP Morgan
Sell
$7.00+8.9% to target
Coverage
—
+ Follow
#4
IZ
Ilya Zubkov
Freedom Capital Markets
Buy
$12.00+86.6% to target
Coverage
—
+ Follow
#5
IZ
Ilya Zubkov
Freedom Broker
Buy
$12.00+86.6% to target
Coverage
—
+ Follow
INGN stock forecast FAQ
What is INGN's average 12-month price target?+
The 1 analysts with a live target average $12.00 for Inogen Inc over the next 12 months, ranging from a $12.00 high to a $12.00 low.
Is INGN stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover INGN?+
1 analysts have an active rating on Inogen Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering INGN?+
Among analysts who currently cover INGN, Mike Matson of Needham has the strongest overall Quantellect track record (Rank #204). Their current call is Buy with a $12.00 target.
What is Inogen Inc's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 1 analysts. Full-year EPS is projected at $-0.37, rising to $-0.26 the following year.
How much revenue is Inogen Inc expected to report next quarter?+
Consensus revenue is $98.7M (range $98.2M – $99.2M). Full-year revenue is projected at $369.3M, growing to $396.8M next year.
Have analysts been upgrading or downgrading INGN lately?+
As of Jul, 1 of 1 firms rate INGN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INGN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
